FDA Device recall Z-1747-2025
FoundationOne Companion Diagnostic (F1CDx)
- FDA Device
- Class II
- ongoing
- Published 2025-05-21
On 2025-05-21 the FDA classified a Class II recall of FoundationOne Companion Diagnostic (F1CDx) by Foundation Medicine, citing four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3)….
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1747-2025 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2025-04-09 |
| Published | 2025-05-21 |
| Last updated | 2026-09-13 11:57 UTC |
| Company | Foundation Medicine |
| Distribution | US |
Product
FoundationOne Companion Diagnostic (F1CDx)
Reason
Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling result changes did not impact CDx indications.
Identifiers
| code_info | ORD-XXXXX28-01 ORD-XXXXX98-01 ORD-XXXXX29-01 ORD-XXXXX99-01 Note: The above characters have been redacted to minimize patient information disclosure. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:57 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1747-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.